Video Observed Treatment is an Innovative Method of Tuberculosis Treatment Observation in Resource-Limited Health Care Settings ; Видеоконтролируемое лечение – инновационный метод мониторинга терапии туберкулеза в условиях ограниченных ресурсов системы здравоохранения

Συγγραφείς: N. A. Pavlyuchenkova, I. A. Vasilyeva, A. G. Samoylova, T. E. Tyulkova, Н. А. Павлюченкова, И. А. Васильева, А. Г. Самойлова, Т. Е. Тюлькова

Πηγή: Tuberculosis and Lung Diseases; Том 100, № 2 (2022); 53-60 ; Туберкулез и болезни легких; Том 100, № 2 (2022); 53-60 ; 2542-1506 ; 2075-1230

Θεματικοί όροι: выгода, innovation, mobile health, video observed therapy, efficiency, benefit, инновации, мобильное здравоохранение, видеоконтролируемая терапия, эффективность

Περιγραφή αρχείου: application/pdf

Relation: https://www.tibl-journal.com/jour/article/view/1617/1626; Елькина И. А., Саранчина С. В., Плохих Д. А. Опыт организации видеоконтролируемого лечения туберкулеза в г. Кемерово // Актуальные вопросы фтизиатрии: материалы межрегиональной научно-практической конференции, посвященной 75-летнему юбилею Кемеровского областного клинического фтизиопульмонологического медицинского центра. ГБУЗ КО КОКФПМЦ; ФГБОУ ВО КемГМУ МЗ России. Кемерово. – 2018. – С. 41-42.; Кадыров А. С., Мырзалиев Б. Б., Ахматов М. Б., Сулайманова М. И. Предварительные результаты пилотирования видео-контролируемого лечения для пациентов с туберкулезом в Кыргызской Республике // Здравоохранение Кыргызстана. – 2019. – № 1. – С. 68-72.; Карпов О. Э., Субботин С. А., Шишканов Д. В., Замятин М. Н. Цифровое здравоохранение. Необходимость и предпосылки // Врач и информационные технологии. – 2017. – № 3. – С. 6-22.; Никитин П. В. Мурадянц А. А., Шостак Н. А. Мобильное здравоохранение: возможности, проблемы, перспективы // Клиницист. – 2015. – Т. 9, № 4. – С. 13-21.; Равильоне М. К., Коробицын А. А. Ликвидация туберкулеза – новая стратегия ВОЗ в эру целей устойчивого развития, вклад Российской Федерации // Туб. и болезни легких. – 2016. – Т. 94, № 11. – С. 7-15.; Alipanah N., Jarlsberg L., Miller C., Linh N. N., Falzon D., Jaramillo E., Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies // PLoS Med. – 2018. – Vol. 15, № 7. – P. e1002595. DOI:10.1371/journal.pmed.1002595.; Bayer R., Wilkinson D. Directly observed therapy for tuberculosis: history of an idea // Lancet. – 1995. – Vol. 345, № 8964. – Р. 1545-1548. DOI:10.1016/s0140-6736(95)91090-5.; Browne S. H., Umlauf A., Tucker A. J., Low J., Moser K., Gonzalez Garcia J., Peloquin C. A., Blaschke T., Vaida F., Benson C.A. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial // PLoS Med. – 2019. – Vol. 16, № 10. – Р. e1002891. DOI:10.1371/journal.pmed.1002891.; Chuck C., Robinson E., Macaraig M., Alexander M., Burzynski J. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City // Int. J. Tuberc. Lung. Dis. – 2016. – Vol. 20, № 5. – P. 588-593. DOI: https://doi.org/10.5588/ijtld.15.0738.; Daley C. L. The global fight against tuberculosis // Thorac. Surg. Clin. – 2019. – Vol. 29, № 1. – P. 19-25. DOI:10.1016/j.thorsurg.2018.09.010.; DeMaio J., Schwartz L., Cooley P. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project // Clin. Infect. Dis. – 2001. – Vol. 33, № 12. – P. 2082-2084. DOI:10.1086/324506.; European Centre for Disease Prevention and Control. Guidance on tuberculosis control in vulnerable and hard-to-reach populations. Stockholm: ECDC (2016). Available at: https://www.ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/TB-guidance-interventions-vulnerable-groups.pdf. [Accessed 4 January, 2020].; Garfein R. S., Collins K., Muñoz F. Moser K., Cerecer-Callu P., Raab F., Rios P., Flick A., Zúñiga M. L., Cuevas-Mota J., Liang K., Rangel G., Burgos J. L., Rodwell T. C., Patrick K. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study // Int. J. Tuberc. Lung. Dis. – 2015. – Vol. 19, № 9. – P. 1057-1064. DOI:10.5588/ijtld.14.0923.; Garfein R. S., Doshi R. P. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support // J. Clin. Tuberc. Other Mycobact. Dis. – 2019. – Vol. 17. – P. 100098. DOI:10.1016/j.jctube.2019.100098.; Garfein R. S., Liu L., Cuevas-Mota J. Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA // Emerg. Infect. Dis. – 2018. – Vol. 24, № 10. – P. 1806-1815. DOI:10.3201/eid2410.180459.; Goldfarb N. M. Improving subject compliance with smart pill bottles // J. Clin. Res. Best Pract. – 2007. – Vol. 8, № 3. – P. 1-5.; Guo P., Qiao W., Sun Y., Liu F., Wang C. Telemedicine technologies and tuberculosis management: a randomized controlled trial // Telemed. J. E-Health. – 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31794684. [Accessed 4 January, 2020]. DOI:10.1089/tmj.2019.0190.; Karumbi J., Garner P. Directly observed therapy for treating tuberculosis // Cochrane Database Syst. Rev. – 2015. – Issue 5. – Art. No.: CD003343. DOI:10.1002/14651858.CD003343.pub4.; Khachtryan N. Video-DOT implementation in Armenia // 5th TB Symposium – Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs of Georgia and Médecins Sans Frontières 22-23 March, 2016, TBILISI, GEORGIA. Available at: http://www.tb-symposium.org/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/naira_khachatryan_video-dot_implementation.pdf. [Accessed 4 January, 2020].; Krueger K., Ruby D., Cooley P., Montoya, B., Exarchos, A., Djojonegoro B. M., Field K. Videophone utilization as an alternative to directly observed therapy for tuberculosis // Int. J. Tuberc. Lung. Dis. – 2010. – Vol. 14, № 6. – P. 779-781.; Kumar A. A., De Costa A., Das A., Srinivasa G., D'Souza G., Rodrigues R. Mobile health for tuberculosis management in South India: Is video-based directly observed treatment an acceptable alternative? // JMIR Mhealth Uhealth. – 2019. – Vol. 7, № 4. – P. e11687. DOI:10.2196/11687.; Lesnic E., Osipov T., Malic A. Eligilibility criteria for video-observed anti-tuberculosis treatment at patients from Chisinau // The Moldovan Med. J. – 2019. – Vol. 62, № 4. – P. 14-20. DOI:10.5281/zenodo.3556469.; Mirsaeidi M., Farshidpour M., Banks-Tripp D., Hashmi S., Kujoth C., Schraufnagel D. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective // Eur. Respir. J. – 2015. – Vol. 46, № 3. – P. 871-874. DOI:10.1183/09031936.00011015.; Nguyen T. A., Pham M. T., Nguyen T. L., Nguyen V. N., Pham D. C., Nguyen B. H., Fox G. J. Video directly observed therapy to support adherence with treatment for tuberculosis in Vietnam: A prospective cohort study // Int. J. Infect. Dis. – 2017. – Vol. 65. – P. 85-89. DOI:10.1016/j.ijid.2017.09.029.; Ngwatu B. K., Nsengiyumva N. P., Oxlade O., Mappin-Kasirer B., Nguyen N. L., Jaramillo E., Falzon D., Schwartzman K. The impact of digital health technologies on tuberculosis treatment: a systematic review // Eur. Respir. J. – 2018. – Vol. 51, № 1. – P. 1701596. DOI:10.1183/13993003.01596-2017.; Olano-Soler H., Thomas D., Joglar O. Notes from the Field: Use of Asynchronous video directly observed therapy for treatment of tuberculosis and latent tuberculosis infection in a long-term – care facility ‒ Puerto Rico, 2016-2017 // MMWR Morb. Mortal Wkly Rep. – 2017. – Vol. 66, № 50. – P. 1386-1387. DOI:10.15585/mmwr.mm6650a5.; Pettit A. C., Jenkins C. A., Blevins Peratikos M. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries // J. Int. AIDS Soc. – 2019. – Vol. 22, № 12. – P. e25423. DOI:10.1002/jia2.25423.; Sagbakken M., Bjune G. A., Frich J. C. Humiliation or care? A qualitative study of patients' and health professionals' experiences with tuberculosis treatment in Norway // Scand. J. Caring Sci. – 2012. – Vol. 26, № 2. – P. 313-23. DOI:10.1111/j.1471-6712.2011.00935.x.; Seiguer J. D S., Rios K., Townsend K. Video DOT Implementation in Maryland: Outcomes & Opportunities. Available at: https://phpa.health.maryland.gov/OIDPCS/CTBCP/CTBCPDocuments/2017%20Annual%20Update/VideoDOT%20(1).pdf. [Accessed 4 January, 2020].; Sinkou H., Hurevich H., Rusovich V., Zhylevicet L., Falzon D., De Colombani P., Dadu А., Dara M., Story А., Skrahina А. Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience // Eur. Respir. J. – 2017. – Vol. 49, № 3. – Р. 1602049. https://doi.org/10.1183/13993003.02049-2016.; Story A., Aldridge R. W., Smith C. M., Garber E., Hall J., Ferenando G., Possas L., Hemming S., Wurie F., Luchenski S., Abubakar I., McHugh T. D., White P. J, Watson J. M., Lipman M., Garfein R., Hayward A. C. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial // Lancet. – 2019. – Vol. 393, № 10177. – P. 1216-1224. DOI:10.1016/S0140-6736(18)32993-3.; Technology Options for Video Directly Observed Therapy (VDOT) MHD. Available at: https://www.health.state.mn.us/diseases/tb/lph/vdot/techoptions.pdf. [Accessed 4 January, 2020].; Wade V. A., Karnon J., Eliott J. A., Hiller J. E. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation // PLoS One. – 2012. – Vol. 7, № 11. – P. e50155. DOI:10.1371/journal.pone.0050155.; World Health Organization. Digital health for the end TB strategy: an agenda for action (2015). Available at: https://www.who.int/tb/areas-of-work/digital-health/Digital_health_EndTBstrategy.pdf. [Accessed 4 January, 2020].; World Health Organization. From innovation to implementation – eHealth in the WHO European Region (2016). Available at: http://www.euro.who.int/__data/assets/pdf_file/0012/302331/From-Innovation-to-Implementation-eHealth-Report-EU.pdf. [Accessed 4 January, 2020].; World Health Organization. Global tuberculosis report 2019. Licence: CC BY-NC-SA 3.0 IGO (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. [Accessed 4 January, 2020].; World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Available at: https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf?sequence=1. [Accessed 4 January, 2020].; World Health Organization. mHealth: new horizons for health through mobile technologies: second global survey on eHealth (2013). Available at: https://extranet.who.int/iris/restricted/bitstream/handle/10665/87688/9789244564257_rus.pdf?sequence=1&isAllowed=y. [Accessed 4 January, 2020].; World Health Organization. The END TB Strategy (2014). Available at: https://www.who.int/tb/strategy/End_TB_Strategy.pdf. [Accessed 4 January, 2020].; World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf. [Accessed 4 January, 2020].

Διαθεσιμότητα: https://www.tibl-journal.com/jour/article/view/1617
https://doi.org/10.21292/2075-1230-2022-100-2-53-60

Video Observed Treatment is an Innovative Method of Tuberculosis Treatment Observation in Resource-Limited Health Care Settings

Συγγραφείς: N. A. Pavlyuchenkova, I. A. Vasilyeva, A. G. Samoylova, T. E. Tyulkova

Πηγή: Туберкулез и болезни лёгких, Vol 100, Iss 2, Pp 53-60 (2022)

Θεματικοί όροι: туберкулез, инновации, мобильное здравоохранение, видеоконтролируемая терапия, эффективность, выгода, Diseases of the respiratory system, RC705-779

Relation: https://www.tibl-journal.com/jour/article/view/1617; https://doaj.org/toc/2075-1230; https://doaj.org/toc/2542-1506; https://doaj.org/article/2a2bdcca8e9a4acfb97f487993394fe3

Διαθεσιμότητα: https://doi.org/10.21292/2075-1230-2022-100-2-53-60
https://doaj.org/article/2a2bdcca8e9a4acfb97f487993394fe3